No cure available for exposure to potentially deadly ionizing radiation
- UVA researchers have identified compounds that could lead to the first antidote for potentially deadly radiation exposure
- Research was spurred by government concern about terror attacks and nuclear accidents
- For people exposed to sufficient ionizing radiation, doctors can only try to ease their suffering until death
- 2016 is the 30th anniversary of the Chernobyl nuclear accident and the fifth anniversary of the Fukushima nuclear accident
University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.
Some of the compounds, including the drug rapamycin, have previously been shown to extend life in organisms such as worms and flies, though it’s unknown if they would have the same benefit in humans. UVA’s research suggests that these compounds, or similar drugs, might counter the deadly effects of ionizing radiation.
Currently there is no treatment for people exposed to lethal doses of radiation; doctors can only try to ease their suffering until death. “If you’re exposed to a very, very high dose, it’s rapid deterioration and immediate death,” explained John S. Lazo, PhD, of UVA’s Department of Pharmacology. “It’s the lower doses that people – particularly governments – are concerned about. The type of exposure that might result from a dirty bomb or a nuclear accident. How do we alleviate the effects? What’s the antidote? Right now, we just don’t have anything.”
Lazo and his colleague Elizabeth R. Sharlow, PhD, screened a library of more than 3,400 existing drugs, vitamins and other compounds to identify ones that might help cells withstand the effects of radiation exposure. The goal was to keep stem cells – the cells that produce the various cell types in the body – alive long enough to repair the damage caused by radiation.
“We wanted to find already approved drugs that would potentially keep stem cells, or progenitor cells, alive after radiation exposure,” Sharlow said. “That’s very much of interest to the NIH [National Institutes of Health] right now: How can we keep those self-renewing populations alive so they can actually help heal the effects of radiation exposure?”
After they identified potential leads, Sharlow created 3D computer models to compare the substances’ chemical structures. That analysis identified a cluster of promising compounds with similar structures – a tantalizing lead in the quest for an antidote. “If you’re a drug hunter, the way we are, this is really cool information,” Lazo said. “Because you can say, ‘Now I will look in the universe of 40 million compounds. What else looks like that? Are they useful?'”
He noted that it is unlikely any one drug or compound will work on its own. “A lot of us in this field think it will be a cocktail of things you take,” he said. “And if you think you need cocktails, you need the individual ingredients. That’s why we think this is pretty important – because it’s providing new ingredients for that cocktail.”
The Latest on: Radiation antidote
[google_news title=”” keyword=”radiation antidote” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Radiation antidote
- Using radiation from the inside out to target canceron December 5, 2023 at 8:05 pm
A novel way to target metastatic cancer is using radiation from the inside out. It’s called theranostics – a radioactive molecule offering a double disease punch simultaneously; ...
- Mosedipimod by Enzychem Lifesciences for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome): Likelihood of Approvalon December 5, 2023 at 12:00 am
It is developed based on lipid medicine platform technology ... atopic dermatitis, acute radiation syndrome, sepsis, and autoimmune disorders. EC-18 is the company’s pipeline product which treats the ...
- PreludeDx to Present New Data on the Clinical Utility of DCISionRT in Australian Patients with DCIS at the 2023 San Antonio Breast Cancer Symposiumon December 4, 2023 at 11:00 pm
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it will present data demonstrating the decision impact on ...
- Radiation treatment could be used to treat heart failure: Studyon December 2, 2023 at 11:58 pm
Cardiologists and radiation oncologists at Washington University School of Medicine in St Louis have pioneered the use of radiation therapy to treat v ...
- Acute Radiation Sickness Warning Signs: What To Look Out Foron December 1, 2023 at 1:28 pm
Overview Illness caused by exposure to large dose of ionizing radiation in a short duration of time. The severity of symptoms such as nausea, vomiting or diarrhea, depends on the type and amount of ...
- Cancer treating radiation therapy may help against heart failureon November 29, 2023 at 3:22 pm
Radiation therapy -- a strategy typically used against cancer -- may help treat patients with a life-threatening abnormal heart rhythm called ventricular tachycardia, suggests a study. Cardiologists ...
- Low-dose radiation therapy may reduce inflammation and improve heart function: Studyon November 29, 2023 at 2:54 pm
an assistant professor of medicine. "We wanted to understand the effects of that low-dose radiation on these patients' hearts. There was concern that it could be harmful to overall heart function, ...
- Study: Radiation Therapy Shows Promise in Treating Heart Failureon November 29, 2023 at 2:21 pm
A pioneering study conducted by cardiologists and radiation oncologists at the Washington University School of Medicine in St Louis unveils th ...
- Radiation therapy may be potential heart failure treatmenton November 28, 2023 at 10:29 am
Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis pioneered the use of radiation therapy—a strategy typically used against cancer—to treat patients with ...
- Radiation therapy could be used to treat heart failure: Studyon November 28, 2023 at 9:30 am
Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis have pioneered the use of low-dose radiation therapy ...
via Bing News